Pay in 4 interest-free payments of $7.26 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Intended Use: For Laboratory Research Use Only Key Characteristics of Tirzepatide (40 mg) Dual incretin receptortargeted peptide for metabolic signaling research Activates both GIP and GLP-1 receptors in experimental models Fatty acid (C20) side-chain modification enhances stability and prolongs receptor interaction Amino acid substitutions improve resistance to enzymatic degradation High purity verified using HPLC and mass spectrometry Supplied in lyophilized form to preserve molecular integrity before reconstitution Ideal for in vitro assays and preclinical metabolic research models How Tirzepatide (40 mg) Supports Research Tirzepatide (40 mg) is utilized in laboratory research to study dual incretin receptor signaling
10.1016/j.molmet.2018.09.009 13 DefronzoR
It is also worth checking with insurance providers to see if they cover either medication
The patient population being studied has been highly enriched for risk: Established ASCVD, moderate CKD and an elevated CRP are all inclusion criteria
Most users do not need to escalate to 15 mg to see meaningful results
Compounded drugs are permitted to be prescribed under federal law but are not FDA-approved and do not undergo safety, effectiveness, or manufacturing review
